Biotechnology and Medical Research (TRBC)

Sanofi, Regeneron skin cancer drug gets FDA nod

Sanofi, Regeneron skin cancer drug gets FDA nod

Published 28/09/2018

(Reuters) - Sanofi SA said on Friday its skin cancer drug, made in partnership with Regeneron Pharmaceuticals Inc, was approved by the U.S. Food and [more…]

U.S. fund investors move to domestic stocks for third straight week

U.S. fund investors move to domestic stocks for third straight week

Published 27/09/2018

NEW YORK (Reuters) - U.S. fund investors rotated from international to domestic stocks for a third straight week, showing continued signs of risk aversion given [more…]

As China builds biotech sector, cash floods U.S. startups

As China builds biotech sector, cash floods U.S. startups

Published 24/09/2018

SAN FRANCISCO/HONG KONG (Reuters) - For three whirlwind days in June, U.S. scientist Zhi Hong went shopping at the Boston Bio Conference to find drugs [more…]

Drug shortages may add $230 million to annual U.S. drug costs

Drug shortages may add $230 million to annual U.S. drug costs

Published 21/09/2018

(Reuters Health) - Prescription drug shortages may drive up prices twice as much as they would rise with medicines in abundant supply, adding $230 million [more…]

Consort, Opiant to develop nasal spray for opioid overdose treatment

Consort, Opiant to develop nasal spray for opioid overdose treatment

Published 10/09/2018

(Reuters) - Britain’s Consort Medical Plc said on Monday it had agreed to develop a nasal spray for treating opioid overdoses with specialty pharmaceutical company [more…]

Agios names former Celgene executive Jacqualyn Fouse as next CEO

Agios names former Celgene executive Jacqualyn Fouse as next CEO

Published 04/09/2018

(Reuters) - Agios Pharmaceuticals Inc on Tuesday said former Celgene Corp executive Jacqualyn Fouse would be its next chief executive officer, replacing longtime CEO David [more…]

Insurance tactic drags down U.S. drug prices in second quarter:…

Insurance tactic drags down U.S. drug prices in second quarter:…

Published 04/09/2018

NEW YORK (Reuters) - U.S. drug prices fell again in the second quarter, likely due to a new tactic insurers are using to limit financial [more…]

Scientists unpick how cannabis component may fight psychosis

Scientists unpick how cannabis component may fight psychosis

Published 30/08/2018

LONDON (Reuters) - British scientists have unraveled how a non-intoxicating component of cannabis acts in key brain areas to reduce abnormal activity in patients at [more…]

Novartis’s Kymriah wins EU approval for blood cancer treatment

Novartis’s Kymriah wins EU approval for blood cancer treatment

Published 27/08/2018

ZURICH (Reuters) - Novartis received European approval for Kymriah, its gene-modifying therapy for blood cancer, but said its introduction will vary from country to country [more…]

FDA approves Teva’s generic of Mylan’s EpiPen

FDA approves Teva’s generic of Mylan’s EpiPen

Published 18/08/2018

(Reuters) - The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd’s generic version of Mylan NV’s life-saving allergy injection, EpiPen, at [more…]